(Q41144260)

27 September 2017

title

Enhanced characterization of contractility in cardiomyocytes during early drug safety assessment (English)

1 reference

27 September 2017

Larissa Butler

1

1 reference

27 September 2017

Caroline Cros

2

1 reference

27 September 2017

Karen L Oldman

3

1 reference

27 September 2017

Alex R Harmer

4

1 reference

27 September 2017

Amy Pointon

5

1 reference

27 September 2017

Christopher E Pollard

6

1 reference

27 September 2017

Najah Abi-Gerges

7

1 reference

27 September 2017

publication date

29 March 2015

1 reference

27 September 2017

published in

Toxicological Sciences

1 reference

27 September 2017

volume

145

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

396-406

1 reference

Preservation of cardiomyocytes from the adult heart

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Dog left ventricular midmyocardial myocytes for assessment of drug-induced delayed repolarization: short-term variability and proarrhythmic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Force/shortening-frequency relationship in multicellular muscle strips and single cardiomyocytes of human failing and nonfailing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: responses to changes in cardiac loading and heart rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Optimal range for parvalbumin as relaxing agent in adult cardiac myocytes: gene transfer and mathematical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Development, interpretation and temporal evaluation of a global QSAR of hERG electrophysiology screening data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Validation of an in vitro contractility assay using canine ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Cultured over Different Spatial Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Cardiac force-frequency relationship and frequency-dependent acceleration of relaxation are impaired in LPS-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Optimizing the experimental environment for dog telemetry studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Rate-dependent Ca2+ signalling underlying the force-frequency response in rat ventricular myocytes: a coupled electromechanical modeling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Role of CaMKIIdelta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

The role of the anaesthetised guinea-pig in the preclinical cardiac safety evaluation of drug candidate compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Cardiotoxicity associated with targeting kinase pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Effect of a single oral dose of milrinone on left ventricular diastolic performance in the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Measurement of cardiac mechanical function in isolated ventricular myocytes from rats and mice by computerized video-based imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Nuclear targeting of Akt enhances ventricular function and myocyte contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Human induced pluripotent stem cells and their use in drug discovery for toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

The role of cell death and myofibrillar damage in contractile dysfunction of long-term cultured adult cardiomyocytes exposed to doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV062

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFV062

1 reference

27 September 2017

1 reference